Skip to main navigation menu Skip to main content Skip to site footer


Vol. 144 No. 3940 (2014)

Abnormal flora and infection in critically ill patients

  • Peter HJ van der Voort
Cite this as:
Swiss Med Wkly. 2014;144:w14024


  1. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013;13:260–68.
  2. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care unit: results of the SOAP study. Crit Care Med. 2006;34:344–53.
  3. Sidler MA, Battegay M, Tschudin-Suttler S, Widmer AF, Weisser M. Enterococci, Clostridium difficile and ESBL-producing bacteria: epidemiology, clinical impact and prevention in ICU patients. Swiss Med Wkly. 2014;144:w14009.
  4. Silvestri L, de la Cal MA, van Saene HK. Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth. Intensive Care Med. 2012;38:1738–50.
  5. Silvestri L, van Saene HK, Casarin A, Berlot G, Gullo A. Impact of selective decontamination of the digestive tract on carriage and infection due to Gram negative and Gram-positive bacteria: a systematic review of randomized controlled trials. Anaesth Intensive Care. 2008;36:324–38.
  6. Houben AJ, Oostdijk EA, van der Voort PH, Monen JC, Bonten MJ, van der Bij AK, et al. Selective decontamination of the oropharynx and the digestive tract, and antimicrobial resistance: a 4 year ecological study in 38 intensive care units in the Netherlands. J Antimicrob Chemother. 2014;69:797–804.
  7. Tschudin Sutter S, Frei R, Dangel M, Gratwohl A, Bonten M, Widmer AF. Not all patients with vancomycin-resistant enterococci need to be isolated. Clin Infect Dis. 2010;51:678–6683.